FDA Seeks Injunction Against Endotec For Premarket Violations
This article was originally published in The Gray Sheet
Executive Summary
FDA announced Oct. 6 it has brought suit against orthopedic implant manufacturer Endotec seeking to permanently halt sales of the firm's total joint replacement devices